Association of ALI and mCONUT With In‐Hospital De Novo Heart Failure in Patients With STEMI
Clinical Cardiology · 2026-11 · 49 (11)
DOI: 10.1002/clc.70526 ↗Abstract
ABSTRACT Background De novo heart failure (HF) during the first ST‐segment elevation myocardial infarction (STEMI) hospitalization significantly increases mortality and readmission. While nutritional and inflammatory indicators like the advanced lung cancer inflammation index (ALI) and modified Controlling Nutritional Status (mCONUT) score are gaining attention, their exact association with post‐STEMI de novo HF remains unclear. Methods This retrospective study (January 2016 to June 2025) included 1598 first‐time STEMI patients undergoing percutaneous coronary intervention. Patients were categorized into de novo HF and non‐HF groups to evaluate the association of ALI and mCONUT scores with HF development. Results The HF group exhibited significantly lower ALI and higher mCONUT scores compared to the non‐HF group. Multivariate logistic regression identified lower ALI and higher mCONUT scores as independent predictors of HF risk. Receiver operating characteristic analysis demonstrated that mCONUT possessed better predictive performance than ALI, with effects remaining highly consistent across subgroups. Sensitivity analyses and NRI/IDI results confirmed that mCONUT provides independent incremental predictive value beyond traditional risk models (optimism‐corrected C ‐statistic 0.785 vs. 0.751). These associations were independent of admission hemodynamic status (Killip class) and treatment era. Conclusion Both ALI and mCONUT scores are independently associated with in‐hospital de novo HF in STEMI patients. The mCONUT score demonstrates superior predictive performance, serving as a promising indicator for early risk stratification.
EUVIMED